***Background.*** Indicators of antimicrobial (AM) use have been described, but the optimal indicator for predicting AM resistance in hospital settings, especially when including pediatric populations, is unknown. This study compared the accuracy of 15 different AM use indicators in the prediction of resistance, in 9 intensive care units (ICUs).

***Methods.*** All patients admitted to participating ICUs (3 neonatal, 2 pediatric, 4 adult) between 2006 and 2010 were studied retrospectively. Prevalence and incidence of resistance in endotracheal cultures were both estimated per 4-week period. AM use was measured, per 4-week period, using 15 different indicators. Resistance / AM use combinations studied were resistance to:

• methicillin in *Staphylococcus aureus* / penicillin + 3^rd^ generation cephalosporins + quinolones use

• aminoglycosides in coliforms / aminoglycoside use

• piperacillin-tazobactam in coliforms / piperacillin-tazobactam use

• quinolones in coliforms / quinolones use

• carbapenems in *E. coli*, *Klebsiella* sp. or *Proteus* sp. / penicillin + carbapenem + quinolone use

• carbapenems in *Pseudomonas* sp. / carbapenem use

• piperacillin-tazobactam in *Pseudomonas* sp. / piperacillin-tazobactam use

• quinolones in *Pseudomonas* sp. / quinolone use

For each combination, indicators of AM use were successively tested in regression models after adjustment for ICU type. Binomial regression was used to model prevalence and Poisson regression, to model incidence. Multiplicative and additive models were tested, as well as no time lag and a 1 period time lag. For each model, the mean absolute error (MAE) was computed. MAEs were then compared using t-tests.

***Results.*** A statistical difference between MAEs could only be detected when using carbapenem use for predicting prevalence of resistance to carbapanems in *Pseudomonas*sp. For this combination, the most accurate indicator (courses/100 patient-days, additive model, no time lag; MAE = 0.31 cases/100 admissions) was better (p = 0.0006) than the least accurate indicator (recommended daily doses/100 admissions, multiplicative model, 1-period time lag; MAE = 0.43 cases/100 admissions, thus 38% bigger).

***Conclusion.*** In our ICUs, indicators of AM use predicted resistance with similar accuracy, except for one combination.
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